Beta Bionics (BBNX) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Beta Bionics is the larger company by market cap ($957.5 million vs $802.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | SGP |
|---|---|---|
| Share price | $17.75 | $24.00 |
| Market cap | $957.55M | $802.75M |
| 1-day change | -1.83% | +0.42% |
| YTD return | -40.66% | — |
| 1-year return | -18.37% | — |
| EPS (TTM) | $-1.64 | $-2.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.71 | $32.44 |
| 52-week low | $8.80 | $17.06 |
| Distance from 52-week high | -45.74% | -26.02% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +34.08% | +83.33% |
| Average volume | 1.30M | 111.13K |
| Shares outstanding | 53.95M | 33.45M |
| Employees | 420 | 76 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Health Care · Medical/Dental Instruments · 420 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 76 employees
BBNX vs SGP FAQ
Which is bigger, Beta Bionics or SpyGlass Pharma?
Beta Bionics (BBNX) is larger, with a market capitalization of $957.55M compared with $802.75M for SpyGlass Pharma (SGP).
Are Beta Bionics and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.